Trials / Unknown
UnknownNCT05105672
A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer
A Single-Arm, Single-Center Phase II Clinical Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in The Treatment of Stage IIA2 To IVA (2018 FIGO) Locally Advanced Cervical Cancer
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a single-arm, single-center phase II clinical study to explore the efficacy and safety of sintilimab combined with concurrent chemoradiation therapy as treatment in women with locally advanced cervical cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sintilimab | IV infusion |
| DRUG | Cisplatin | IV infusion |
| RADIATION | External Beam Radiotherapy (EBRT) | Undergo pelvic EBRT |
| RADIATION | brachytherapy | brachytherapy |
Timeline
- Start date
- 2021-03-08
- Primary completion
- 2023-03-01
- Completion
- 2024-03-01
- First posted
- 2021-11-03
- Last updated
- 2021-12-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05105672. Inclusion in this directory is not an endorsement.